These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27703221)
1. The Principles of Ligand Specificity on beta-2-adrenergic receptor. Chan HC; Filipek S; Yuan S Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221 [TBL] [Abstract][Full Text] [Related]
2. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study. Kooistra AJ; Leurs R; de Esch IJ; de Graaf C J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966 [TBL] [Abstract][Full Text] [Related]
3. Ligand-binding affinity of alternative conformers of human β Dilcan G; Doruker P; Akten ED Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937 [TBL] [Abstract][Full Text] [Related]
4. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. Vilar S; Karpiak J; Berk B; Costanzi S J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234 [TBL] [Abstract][Full Text] [Related]
5. Influence of lipid composition on the structural stability of g-protein coupled receptor. Mahmood I; Liu X; Neya S; Hoshino T Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002 [TBL] [Abstract][Full Text] [Related]
6. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation. Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155 [TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
8. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics. Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802 [TBL] [Abstract][Full Text] [Related]
9. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. Wacker D; Fenalti G; Brown MA; Katritch V; Abagyan R; Cherezov V; Stevens RC J Am Chem Soc; 2010 Aug; 132(33):11443-5. PubMed ID: 20669948 [TBL] [Abstract][Full Text] [Related]
10. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234 [TBL] [Abstract][Full Text] [Related]
11. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening? Tang H; Wang XS; Hsieh JH; Tropsha A Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072 [TBL] [Abstract][Full Text] [Related]
12. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor. Zocher M; Fung JJ; Kobilka BK; Müller DJ Structure; 2012 Aug; 20(8):1391-402. PubMed ID: 22748765 [TBL] [Abstract][Full Text] [Related]
13. Modeling GPCR active state conformations: the β(2)-adrenergic receptor. Simpson LM; Wall ID; Blaney FE; Reynolds CA Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626 [TBL] [Abstract][Full Text] [Related]
14. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. West GM; Chien EY; Katritch V; Gatchalian J; Chalmers MJ; Stevens RC; Griffin PR Structure; 2011 Oct; 19(10):1424-32. PubMed ID: 21889352 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
16. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes. Isin B; Estiu G; Wiest O; Oltvai ZN PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric homogeneous method for identification of ligand binding to G protein-coupled receptors: receptor-ligand binding and β-arrestin assay. Kopra K; Kainulainen M; Mikkonen P; Rozwandowicz-Jansen A; Hänninen P; Härmä H Anal Chem; 2013 Feb; 85(4):2276-81. PubMed ID: 23330639 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region. Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Maeda M; Tsujishita H; Shimada I Nat Commun; 2012; 3():1045. PubMed ID: 22948827 [TBL] [Abstract][Full Text] [Related]
19. Structural features of β2 adrenergic receptor: crystal structures and beyond. Bang I; Choi HJ Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861 [TBL] [Abstract][Full Text] [Related]
20. Bitopic Ligands Support the Presence of a Metastable Binding Site at the β Gaiser BI; Danielsen M; Xu X; Røpke Jørgensen K; Fronik P; Märcher-Rørsted E; Wróbel TM; Liu X; Mosolff Mathiesen J; Sejer Pedersen D J Med Chem; 2024 Jul; 67(13):11053-11068. PubMed ID: 38952152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]